Earlier versions of a spending cuts package passed through Congress targeted PEPFAR. But the White House, concerned about ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

The joint statement, published by LGBT rights group Justice for Sisters (JFS) and endorsed by Suara Rakyat Malaysia (Suaram), ...

Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...

After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

HIV care and its related outcomes in South Carolina were defined by racial disparities, specifically in retention in care, ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

PEPFAR was launched in 2003 to stop the spread of HIV in Africa. Now, although some funding remains for the program, many of ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...